A team of genomic
researchers from two institutes has identified 73 novel variants of the COVID-19 strain in Odisha, its head has said.
The researchers are from CSIR-Institute of Genomics and Integrative Biology (IGIB), New Delhi and Institute of Medical Sciences and SUM Hospital, Bhubaneswar, he said.
"The research team, which carried out sequencing of 1,536 samples including 752 clinical samples, reported two lineages -- B.1.112 and B.1.99 -- for the first time in India," Dr Jayashankar Das, lead investigator and director (research) of the IMS and SUM Hospital, said on Friday.
If one gets to know the detailed character of the novel coronavirus, it will be very easy to treat patients and cure them, he said.
The research team, supported by the Council of Scientific and Industrial Research (CSIR), validated the most-advanced COVID-19 sequencing technology. This could be a potential high-sensitivity assay for the detection of SARS- CoV-2 with the additional advantage of enabling genetic epidemiology of SARS-CoV-2, Das said.
With this study, India has beaten 12 organisations in 10 countries to complete the first field validation and release the data online, he said, quoting a report by sequencing tech giant Illumina.
The IMS and SUM Hospital researchers are also undertaking the sequencing and analysis of 500 viral genomes to understand the mild, moderate and critical coronavirus infection along with its transmission capabilities, he said.
Besides, the study will help understand the vulnerability of the strains, new therapeutic target and new mutation in eastern India, especially in Odisha, Das said.
The rapid emergence of COVID-19 as a pandemic, which has affected millions of people across the world, has necessitated sensitive and high-throughput approaches for the diagnosis, surveillance and determining the genetic epidemiology of SARS-CoV-2, which will help in tracking strain information as well, he said.
Asked about the difference between RT-PCR test and COVID-19 sequencing tests, Das said, "The COVID-19 sequencing reports give the entire history of the coronavirus, while the RT-PCR tests only determine whether a patient is positive or negative for the infection.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)